Stock Report

Download full stock data and analysis for free Last Updated: 04-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Arvee Laboratories Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ARVEE

₹165.00

up-down-arrow ₹-0.81 (-0.49%)

As on 03-Sep-2026 15:31IST

Market cap

info icon

₹182 Cr

Revenue (TTM)

info icon

₹41 Cr

P/E Ratio

info icon

44.9

P/B Ratio

info icon

5.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 59.43 130.28 16.67 -11.31 -2.74
EBIT 175.76 4,427.08 220.70 -8.47 2.43
Net Profit 227.03 902.37 194.61 5.31 8.43
EPS 226.99 902.09 194.60 5.31 8.43
Book Value -- -- 7.38 9.30 10.90
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info 6.547.109.956.394.74
Net Margin info 5.155.479.655.493.39
Return on equity info 8.8810.2812.417.113.68
Return on Capital info 13.4613.94--10.007.03
Return on Assets info 6.346.539.945.642.72
Debt to Equity (x) info ----0.030.030.03

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
--
10.00
7.03
23.35
13.33
Peer Median
--
12.06
13.53
--
21.96
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

12.41

Higher than Peers by 2.93

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
12.41
7.11
3.68
15.84
11.36
Peer Median
9.48
8.91
10.80
--
16.28
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

9.94

Higher than Peers by 3.70

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
9.94
5.64
2.72
10.65
6.46
Peer Median
6.24
5.64
6.79
--
12.29
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

9.95

Higher than Peers by 1.08

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
9.95
6.39
4.74
8.48
8.19
Peer Median
8.87
8.43
8.97
--
11.95
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

9.65

Higher than Peers by 3.10

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
9.65
5.49
3.39
6.57
6.30
Peer Median
6.55
5.96
6.62
--
9.57
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
0.00
8.56
8.40
10.10
12.14
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

16.67

Higher than Peers by 10.58

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
16.67
26.83
-50.54
52.12
-14.88
Peer Median
6.09
9.42
9.36
--
29.50
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

220.70

Higher than Peers by 219.76

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
220.70
71.00
-72.33
57.46
-9.07
Peer Median
0.94
1.79
-1.67
--
8.94
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

194.61

Higher than Peers by 192.50

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
194.61
104.15
-74.46
60.04
-3.87
Peer Median
2.12
-1.10
4.91
--
13.50
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

194.60

Higher than Peers by 192.73

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
194.60
104.15
-74.46
60.04
-3.86
Peer Median
1.88
0.15
4.91
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
--
7.38
3.75
17.22
12.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.03

Higher than Peers by 0.00

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
0.03
0.03
0.03
0.04
0.13
Peer Median
0.03
0.16
0.08
--
0.13
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
--
--
--
--
0.09
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.35

Higher than Peers by 1.28

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
3.35
5.14
2.38
2.44
1.75
Peer Median
2.07
2.23
2.18
--
1.93
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.13

Higher than Peers by 0.68

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
2.13
3.95
1.49
1.92
1.33
Peer Median
1.45
1.96
1.71
--
1.31
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

18.67

Higher than Peers by 9.82

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
18.67
12.56
8.33
16.89
10.31
Peer Median
8.85
8.85
10.17
--
14.41
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

25.33

Higher than Peers by 6.72

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
25.33
21.82
20.14
19.99
30.07
Peer Median
18.61
18.32
17.58
--
17.99
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.01

Higher than Peers by 0.22

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
1.01
1.01
0.79
1.59
1.01
Peer Median
0.80
0.84
0.85
--
1.11
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
--
68.81
110.50
72.55
90.55
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
--
51.92
65.94
30.63
59.55
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
--
87.33
180.60
82.15
157.69
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
--
33.40
-4.16
21.03
-7.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

44.92

Higher than Peers by 8.73

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
44.92
72.87
150.24
23.54
48.68
Peer Median
36.19
35.43
34.02
--
27.79
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

5.12

Higher than Peers by 2.38

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
5.12
5.01
5.43
3.46
5.23
Peer Median
2.75
2.26
2.74
--
3.55
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
--
--
--
--
--
Peer Median
0.27
0.30
0.28
--
0.36
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

29.74

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
29.74
35.75
43.93
11.25
20.16
Peer Median
--
23.67
19.92
--
19.44
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

182

Lower than Peers by 2,420

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Arvee Laboratories
182
156
158
97
125
Peer Median
2,602
920
1,568
--
1,526
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...